Remove tag we-communications
article thumbnail

Grand Rounds February 2, 2024: Strategies for Improving Public Understanding of FDA and the Products It Regulates…Why Should We Care, and What Might We Do? (Susan C. Winckler, RPh, Esq)

Rethinking Clinical Trials

Food and Drug Administration, FDA, Misinformation, Communication, Health Information Key Points U.S. They held roundtable conversations with experts to understand their thoughts on what the FDA might do to better communicate, and they conducted polls and held 25 individual interviews.             Speaker Susan C.

article thumbnail

Grand Rounds December 8, 2023: A Pragmatic Randomized Trial of the Jumpstart Intervention to Promote Communication about Goals of Care for Hospitalized Patients with Serious Illness (Ruth Engelberg, PhD; Erin Kross, MD; Robert Lee, MD, MS)

Rethinking Clinical Trials

The Jumpstart intervention is a communication-priming intervention. The research question Jumpstart set out to answer is can a patient-specific, clinician-facing communication priming intervention with discussion prompts effectively promote goals of care discussions between clinicians and hospitalized older adults with serious illness?

Trials 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds January 12, 2024: Design and Implementation of a Weighted Lottery to Equitably Allocate Scarce Covid-19 Resources (Erin K. McCreary, PharmD, BCIDP)

Rethinking Clinical Trials

The COVID Therapeutics Committee created communication materials to be transparent and to get buy-in. We have a few hypotheses. We went through every iteration of how do you contact patients. We know there is a digital gap in disadvantaged patients and elderly patients. Any hypothesis for why this occurred?

article thumbnail

‘Click’ chemistry used to tag proteins made by cancer cells 

Drug Discovery World

In their study, published in Nature Communications, the team developed a new method that identifies proteins released by a specific type of cell, even if the cells are in a complex environment with lots of other cell types. . The new method involves adding chemical tags to sugar molecules which are added to cells. Click’ chemistry .

Protein 52
article thumbnail

Grand Rounds July 15, 2022: Overview of Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Public-Private Partnership and Lessons Learned (Stacey J. Adam, PhD)

Rethinking Clinical Trials

Having the ability to use the resources from the public and private sectors as much as possible, having sufficient funding and staffing, and having clear communication were all quintessential to getting things running quickly. We selected 35 and completed testing of 27 of them. The team reviewed 800 candidates over 2 years time.

article thumbnail

Grand Rounds Ethics and Regulatory Series November 11, 2022: Data Sharing and Pragmatic Clinical Trials: Law & Ethics Amidst a Changing Policy Landscape (Stephanie Morain, PhD, MPH; Kayte Spector-Bagdady, JD, MBioethics)

Rethinking Clinical Trials

If public demand for greater data sharing is to be driven by awareness of its benefits, then PCTs need to do a better job measuring and communicating about the benefits. – How can we include diverse communities in this discussion especially in terms of trust? Discussion Themes. pctGR, @Collaboratory1.

article thumbnail

Grand Rounds September 16, 2022: Using Nationwide Registries to Conduct Pragmatic Randomized Trials: The DANFLU Program (Tor Biering-Sørensen, MD, PhD, MPH)

Rethinking Clinical Trials

The system is used for priority communications from government agencies, hospitals, banks, and others, and allows for rapid delivery of recruitment letters and implementation interventions. million citizens will be randomized to receive 10 different communications. We would not expect this recruitment rate in other trials.

Trials 130